4//SEC Filing
Eiger BioPharmaceuticals, Inc. 4
Accession 0001209191-17-020655
CIK 0001305253operating
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 7:37 PM ET
Size
5.4 KB
Accession
0001209191-17-020655
Insider Transaction Report
Form 4
Quan Joanne
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-03-09+30,000→ 30,000 totalExercise: $11.75Exp: 2027-03-09→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 48 months measured from March 9, 2017 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeoperating
Related Parties
1- filerCIK 0001305253
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 7:37 PM ET
- Size
- 5.4 KB